Literature DB >> 18179138

Urban-rural differences in gynaecological cancer occurrence in a central region of Italy: 1978-1982 and 1998-2002.

L Minelli1, F Stracci, T Cassetti, A Canosa, M Scheibel, I E Sapia, C Romagnoli, F La Rosa.   

Abstract

Differences in gynaecological cancer incidence and mortality in the urban and rural areas of the Umbria region (central Italy) were investigated. All women with primary invasive breast cancers, uterine cervix and uterine corpus, and ovarian cancers diagnosed during the periods 1978-1982 and 1998-2002 were identified and analysed according to place of residence (either urban or rural). Mortality data were supplied by the National Institute of Statistics (ISTAT) for the period 1978 to 1982, whereas for the 1994-2002 period they were supplied by the Regional Nominative Causes of Death Registry (ReNCaM). Incident cases considered were taken from an ad hoc survey for the first period and from the Umbrian Population Cancer Registry database for the second one. For each site the age-adjusted incidence (AAIR) and mortality (AADR) rates were calculated. The expected number of rural cases was obtained from indirect standardisation with urban incidence and mortality rates of several sites. The significance of the observed expected ratios (SIRs for incidence and SMRs for mortality) and the corresponding 95% confidence intervals were based on the Poisson distribution. Urbanisation levels were established following the classification of the Italian Institute of Statistics. For all sites, excluding the ovary during the most recent period, the SIR relative to rural areas was below 1, but the rates were statistically significant only for breast cancer in both periods (SIR 0.81, 95% CI 0.74-0.88 and SIR 0.82, 95% CI 0.77-0.88, respectively) and for cervix uteri in the first period (SIR 0.77, 95% CI 0.59-0.94). The lower breast cancer incidence in the rural area could also be due to lesser compliance with screening procedures which, up until 2002, were not provided in the form of mass-screenings throughout the region by the Regional Health Department. These results underscore the need for continued efforts to provide preventive health services to medically underserved women throughout Umbria, including rural communities. Underutilisation of preventive healthcare services may result in failure to identify healthcare problems that might be successfully managed with medication or lifestyle changes, as well as missed opportunities to prevent potentially life-threatening diseases.

Entities:  

Mesh:

Year:  2007        PMID: 18179138

Source DB:  PubMed          Journal:  Eur J Gynaecol Oncol        ISSN: 0392-2936            Impact factor:   0.196


  5 in total

1.  Inequalities in noncommunicable disease mortality in the ten largest Japanese cities.

Authors:  Megumi Kano; Miyuki Hotta; Amit Prasad
Journal:  J Urban Health       Date:  2013-12       Impact factor: 3.671

2.  Life in urban areas and breast cancer risk in the French E3N cohort.

Authors:  Blandine Binachon; Laure Dossus; Aurélie M N Danjou; Francoise Clavel-Chapelon; Beatrice Fervers
Journal:  Eur J Epidemiol       Date:  2014-08-20       Impact factor: 8.082

3.  Rural-metropolitan disparities in ovarian cancer survival: a statewide population-based study.

Authors:  Jihye Park; Brenna E Blackburn; Kerry Rowe; John Snyder; Yuan Wan; Vikrant Deshmukh; Michael Newman; Alison Fraser; Ken Smith; Kim Herget; Lindsay Burt; Theresa Werner; David K Gaffney; Ana Maria Lopez; Kathi Mooney; Mia Hashibe
Journal:  Ann Epidemiol       Date:  2018-04-12       Impact factor: 3.797

4.  Cancer incidence in urban, rural, and densely populated districts close to core cities in Bavaria, Germany.

Authors:  M Radespiel-Tröger; K Geiss; D Twardella; W Maier; M Meyer
Journal:  Int Arch Occup Environ Health       Date:  2017-10-12       Impact factor: 3.015

5.  Changing Incidence of Uterine Cancer in Rural Egypt: Possible Impact of Nutritional and Epidemiologic Transitions.

Authors:  Saad Alshahrani; Ahmed Hablas; Robert M Chamberlain; Jane Meza; Steven Remmenga; Ibrahim A Seifeldin; Mohamed Ramadan; Amr S Soliman
Journal:  J Glob Oncol       Date:  2019-07
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.